In this paper, GENEVESTIGATOR^® was used to investigate the expression of SOCS2 in human cancer samples and determine in which cancer types SOCS2 is highly expressed. As SOCS2 encodes a suppressor of cytokine signaling it is discussed as attractive therapeutic target for cancer, diabetes and other diseases where inflammation plays a critical role.

Similar types of analysis can easily be done using GENEVESTIGATOR^®.

See more citations